申请人:Kyowa Hakko Kirin Co., Ltd.
公开号:EP2050734A1
公开(公告)日:2009-04-22
The present invention provides a pentadienamide derivative represented by the formula (I):
(wherein R1 represents substituted or unsubstituted aryl or a substituted or unsubstituted aromatic heterocyclic group;
R2 represents substituted or unsubstituted aryl, a substituted or unsubstituted aromatic heterocyclic group, a substituted or unsubstituted heteroalicyclic group, or the like;
R3 represents a hydrogen atom or is combined together with R4 and the adjacent nitrogen atom thereto to form a substituted or unsubstituted heterocyclic group;
R4 represents substituted or unsubstituted aryl, a substituted or unsubstituted aromatic heterocyclic group, a substituted or unsubstituted heteroalicyclic group, or the like, or is combined together with R3 and the adjacent nitrogen atom thereto to form a substituted or unsubstituted heterocyclic group; and
R5, R6, and R7 may be the same or different, and each represents a hydrogen atom or methyl)
or a pharmaceutically acceptable salt thereof, and the like.
本发明提供了一种由式(I)表示的戊二烯酰胺衍生物:(其中R1代表取代或未取代的芳基或取代或未取代的芳香族杂环基;R2代表取代或未取代的芳基、取代或未取代的芳香族杂环基、取代或未取代的杂环螺环基或类似物;R3代表氢原子或与R4及其相邻的氮原子结合形成取代或未取代的杂环基;R4代表取代或未取代的芳基、取代或未取代的芳香族杂环基、取代或未取代的杂环螺环基或类似物,或与R3及其相邻的氮原子结合形成取代或未取代的杂环基;R5、R6和R7可以相同也可以不同,每个代表氢原子或甲基)或其药学上可接受的盐等。